FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Erdenechimeg Shagdarsuren

Research Profile

Chemicals & Drugs

Living Beings

Disorders

Anatomy

Co-author Network

Publications

TOP 3
Yvonne Döring; Maik Drechsler; Helene Hartwig; Thomas Hieronymus; Mihail Hristov; Rory R Koenen; Svenja Meiler; Erdenechimeg Shagdarsuren; Oliver Soehnlein; Christian Weber; Martin Zenke; Sweena M Chaudhari; Alma Zernecke
Hematopoietic interferon regulatory factor 8-deficiency accelerates atherosclerosis in mice.
Erdenechimeg Shagdarsuren; Kiril Bidzhekov; Sebastian F Mause; Sakine Simsekyilmaz; Thomas Polakowski; Heiko Hawlisch; J Engelbert Gessner; Alma Zernecke; Christian Weber
C5a receptor targeting in neointima formation after arterial injury in atherosclerosis-prone mice.
Alma Zernecke; Kiril Bidzhekov; Heidi Noels; Erdenechimeg Shagdarsuren; Lin Gan; Bernd Denecke; Mihail Hristov; Thomas Köppel; Maliheh Nazari Jahantigh; Esther Lutgens; Shusheng Wang; Eric N Olson; Andreas Schober; Christian Weber
Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Erdenechimeg Shagdarsuren (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Yvonne Döring; Maik Drechsler; Helene Hartwig; Thomas Hieronymus; Mihail Hristov; Rory R Koenen; Svenja Meiler; Erdenechimeg Shagdarsuren; Oliver Soehnlein; Christian Weber; Martin Zenke; Sweena M Chaudhari; Alma Zernecke
Hematopoietic interferon regulatory factor 8-deficiency accelerates atherosclerosis in mice.
Arteriosclerosis, thrombosis, and vascular biology 2012;32(7):1613-23.
2010: Erdenechimeg Shagdarsuren; Kiril Bidzhekov; Sebastian F Mause; Sakine Simsekyilmaz; Thomas Polakowski; Heiko Hawlisch; J Engelbert Gessner; Alma Zernecke; Christian Weber
C5a receptor targeting in neointima formation after arterial injury in atherosclerosis-prone mice.
Circulation 2010;122(10):1026-36.
2009: Alma Zernecke; Kiril Bidzhekov; Heidi Noels; Erdenechimeg Shagdarsuren; Lin Gan; Bernd Denecke; Mihail Hristov; Thomas Köppel; Maliheh Nazari Jahantigh; Esther Lutgens; Shusheng Wang; Eric N Olson; Andreas Schober; Christian Weber
Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection.
Science signaling 2009;2(100):ra81.
2009: Erdenechimeg Shagdarsuren; Yassin Djalali-Talab; michel AURRAND-LIONS; Kiril Bidzhekov; Elisa A Liehn; Beat A Imhof; Christian Weber; Alma Zernecke
Importance of junctional adhesion molecule-C for neointimal hyperplasia and monocyte recruitment in atherosclerosis-prone mice-brief report.
Arteriosclerosis, thrombosis, and vascular biology 2009;29(8):1161-3.
2009: Limor Landsman; Liat Bar-On; Alma Zernecke; Ki-Wook Kim; Rita Krauthgamer; Erdenechimeg Shagdarsuren; sergio lira; Irving L Weissman; Christian Weber; Steffen Jung
CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival.
Blood 2009;113(4):963-72.
2008: Alma Zernecke; Erdenechimeg Shagdarsuren; Christian Weber
Chemokines in atherosclerosis: an update.
Arteriosclerosis, thrombosis, and vascular biology 2008;28(11):1897-908.
2008: Petra Gratze; Ralf Dechend; Carolin Stocker; Joon-Keun Park; Sandra Feldt; Erdenechimeg Shagdarsuren; Maren Wellner; Faikah Gueler; Song Rong; Volkmar Gross; Michael Obst; Ralph Plehm; Natalia Alenina; Ana Zenclussen; Jens Titze; Kersten Small; Yoshifumi Yokota; Martin Zenke; Friedrich C Luft; Dominik N Muller
Novel role for inhibitor of differentiation 2 in the genesis of angiotensin II-induced hypertension.
Circulation 2008;117(20):2645-56.
2008: Elisa A Liehn; Marc W Merx; Otilia Postea; S Becher; Y Djalali-Talab; Erdenechimeg Shagdarsuren; Malte Kelm; Alma Zernecke; Christian Weber
Ccr1 deficiency reduces inflammatory remodelling and preserves left ventricular function after myocardial infarction.
Journal of cellular and molecular medicine 2008;12(2):496-506.
2008: Alma Zernecke; Ilze Bot; Yassin Djalali-Talab; Erdenechimeg Shagdarsuren; Kiril Bidzhekov; Svenja Meiler; Regina Krohn; Andreas Schober; Markus Sperandio; Oliver Soehnlein; Jörg Bornemann; Frank Tacke; Erik A L Biessen; Christian Weber
Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis.
Circulation research 2008;102(2):209-17.
2008: Erdenechimeg Shagdarsuren; Kiril Bidzhekov; Yassin Djalali-Talab; Elisa A Liehn; Mihail Hristov; Robert A Matthijsen; Wim A Buurman; Alma Zernecke; Christian Weber
C1-esterase inhibitor protects against neointima formation after arterial injury in atherosclerosis-prone mice.
Circulation 2008;117(1):70-8.
2007: Regina Krohn; Ute Raffetseder; Ilze Bot; Alma Zernecke; Erdenechimeg Shagdarsuren; Elisa A Liehn; Peter J Van Santbrink; Peter J Nelson; Erik A L Biessen; Peter R Mertens; Christian Weber
Y-box binding protein-1 controls CC chemokine ligand-5 (CCL5) expression in smooth muscle cells and contributes to neointima formation in atherosclerosis-prone mice.
Circulation 2007;116(16):1812-20.
2007: Robert Fischer; Ralf Dechend; Andrej Gapelyuk; Erdenechimeg Shagdarsuren; Konstanze Gruner; Andreas Gruner; Petra Gratze; Fatimunnisa Qadri; Maren Wellner; Anette Fiebeler; Rainer Dietz; Friedrich C Luft; Dominik N Muller; Alexander Schirdewan
Angiotensin II-induced sudden arrhythmic death and electrical remodeling.
American journal of physiology. Heart and circulatory physiology 2007;293(2):H1242-53.
2007: Carolin Deiner; Erdenechimeg Shagdarsuren; Peter L Schwimmbeck; Peter Rosenthal; Christoph Loddenkemper; Ursula Rauch; Matthias Pauschinger; Rainer Dietz; Heinz-Peter Schultheiss; Ralf Dechend; Klaus Pels
Nf-kappab and AP-1 activation is associated with late lumen loss after porcine coronary angioplasty and antiproliferative beta-irradiation.
Cardiovascular research 2007;75(1):195-204.
2007: Ralf Dechend; Erdenechimeg Shagdarsuren; Petra Gratze; Anette Fiebeler; Bernhard Pilz; Silke Meiners; Wolfgang Derer; David L Feldman; Randy Webb; Dominik N Muller
Low-dose renin inhibitor and low-dose AT(1)-receptor blocker therapy ameliorate target-organ damage in rats harbouring human renin and angiotensinogen genes.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2007;8(2):81-4.
2007: Mihail Hristov; Alma Zernecke; Kiril Bidzhekov; Elisa A Liehn; Erdenechimeg Shagdarsuren; Andreas Ludwig; Christian Weber
Importance of CXC chemokine receptor 2 in the homing of human peripheral blood endothelial progenitor cells to sites of arterial injury.
Circulation research 2007;100(4):590-7.
2007: Anette Fiebeler; Dominik N Muller; Erdenechimeg Shagdarsuren; Friedrich C Luft
Aldosterone, mineralocorticoid receptors, and vascular inflammation.
Current opinion in nephrology and hypertension 2007;16(2):134-42.
2007: Joon-Keun Park; Robert Fischer; Ralf Dechend; Erdenechimeg Shagdarsuren; Andrej Gapeljuk; Maren Wellner; Silke Meiners; Petra Gratze; Nidal al-Saadi; Sandra Feldt; Anette Fiebeler; Jeffrey Madwed; Alexander Schirdewan; Hermann Haller; Friedrich C Luft; Dominik N Muller
p38 mitogen-activated protein kinase inhibition ameliorates angiotensin II-induced target organ damage.
Hypertension 2007;49(3):481-9.
2007: Vincent Braunersreuther; Alma Zernecke; Claire Arnaud; Elisa A Liehn; Sabine Steffens; Erdenechimeg Shagdarsuren; Kiril Bidzhekov; Fabienne Burger; Graziano Pelli; Bruno Luckow; François Mach; Christian Weber
Ccr5 but not Ccr1 deficiency reduces development of diet-induced atherosclerosis in mice.
Arteriosclerosis, thrombosis, and vascular biology 2007;27(2):373-9.
2005: Erdenechimeg Shagdarsuren; Maren Wellner; Jan-Hinrich Braesen; Joon-Keun Park; Anette Fiebeler; Norbert Henke; Ralf Dechend; Petra Gratze; Friedrich C Luft; Dominik N Muller
Complement activation in angiotensin II-induced organ damage.
Circulation research 2005;97(7):716-24.
2005: Bernhard Pilz; Erdenechimeg Shagdarsuren; Maren Wellner; Anette Fiebeler; Ralf Dechend; Petra Gratze; Silke Meiners; David L Feldman; Randy L Webb; Ingrid M Garrelds; AH Jan Danser; Friedrich C Luft; Dominik N Müller
Aliskiren, a human renin inhibitor, ameliorates cardiac and renal damage in double-transgenic rats.
Hypertension 2005;46(3):569-76.
2005: Anette Fiebeler; Jürg Nussberger; Erdenechimeg Shagdarsuren; Song Rong; Georg Hilfenhaus; Nidal al-Saadi; Ralf Dechend; Maren Wellner; Silke Meiners; Christiane Maser-Gluth; Arco Y Jeng; Randy L Webb; Friedrich C Luft; Dominik N Muller
Aldosterone synthase inhibitor ameliorates angiotensin II-induced organ damage.
Circulation 2005;111(23):3087-94.
2005: Ralf Dechend; Petra Gratze; Gerd Wallukat; Erdenechimeg Shagdarsuren; Ralph Plehm; Jan Hinrich Bräsen; Anette Fiebeler; Wolfgang Schneider; Silvia Caluwaerts; Lisbeth Vercruysse; Robert Pijnenborg; Friedrich C Luft; Dominik N Müller
Agonistic autoantibodies to the AT1 receptor in a transgenic rat model of preeclampsia.
Hypertension 2005;45(4):742-6.
2005: Maren Wellner; Ralf Dechend; Joon-Keun Park; Erdenechimeg Shagdarsuren; Nidal al-Saadi; Torsten Kirsch; Petra Gratze; Wolfgang Schneider; Silke Meiners; Anette Fiebeler; Hermann Haller; Friedrich C Luft; Dominik N Muller
Cardiac gene expression profile in rats with terminal heart failure and cachexia.
Physiological genomics 2005;20(3):256-67.
2005: Juergen Theuer; Erdenechimeg Shagdarsuren; Dominik N Muller; Eva Kaergel; Horst Honeck; Joon-Keun Park; Anette Fiebeler; Ralf Dechend; Hermann Haller; Friedrich C Luft; Wolf-Hagen Schunck
Inducible NOS inhibition, eicosapentaenoic acid supplementation, and angiotensin II-induced renal damage.
Kidney international 2005;67(1):248-58.
2004: Istvan Mazak; Anette Fiebeler; Dominik N Muller; Joon-Keun Park; Erdenechimeg Shagdarsuren; Carsten Lindschau; Ralf Dechend; Christiane Viedt; Bernhard Pilz; Hermann Haller; Friedrich C Luft
Aldosterone potentiates angiotensin II-induced signaling in vascular smooth muscle cells.
Circulation 2004;109(22):2792-800.
2004: Volkmar Gross; Michael Obst; Eva Kiss; Jürgen Janke; Istvan Mazak; Erdenechimeg Shagdarsuren; Dominik N Müller; Thomas Langenickel; Hermann-Josef Gröne; Friedrich C Luft
Cardiac hypertrophy and fibrosis in chronic L-NAME-treated AT2 receptor-deficient mice.
Journal of hypertension 2004;22(5):997-1005.
2004: Dominik N Muller; Juergen Theuer; Erdenechimeg Shagdarsuren; Eva Kaergel; Horst Honeck; Joon-Keun Park; Marija Markovic; Eduardo Barbosa-Sicard; Ralf Dechend; Maren Wellner; Torsten Kirsch; Anette Fiebeler; Michael Rothe; Hermann Haller; Friedrich C Luft; Wolf-Hagen Schunck
A peroxisome proliferator-activated receptor-alpha activator induces renal CYP2C23 activity and protects from angiotensin II-induced renal injury.
The American journal of pathology 2004;164(2):521-32.
2002: Dominik N Muller; Erdenechimeg Shagdarsuren; Joon-Keun Park; Ralf Dechend; Eero Mervaala; Franziska Hampich; Anette Fiebeler; Xinsheng Ju; Piet Finckenberg; Juergen Theuer; Christiane Viedt; Jörg Kreuzer; Harald Heidecke; Hermann Haller; Martin Zenke; Friedrich C Luft
Immunosuppressive treatment protects against angiotensin II-induced renal damage.
The American journal of pathology 2002;161(5):1679-93.
2002: Eva Kaergel; Dominik N Muller; Horst Honeck; Juergen Theuer; Erdenechimeg Shagdarsuren; Alexander Mullally; Friedrich C Luft; Wolf-Hagen Schunck
P450-dependent arachidonic acid metabolism and angiotensin II-induced renal damage.
Hypertension 2002;40(3):273-9.
2001: Dominik N Muller; Vigo Heissmeyer; Ralf Dechend; Franziska Hampich; Joon-Keun Park; Anette Fiebeler; Erdenechimeg Shagdarsuren; Juergen Theuer; Marlies Elger; Bernhard Pilz; V Breu; K Schroer; Detlev Ganten; Rainer Dietz; Hermann Haller; Claus Scheidereit; Friedrich C Luft
Aspirin inhibits NF-kappaB and protects from angiotensin II-induced organ damage.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2001;15(10):1822-4.
2001: Anette Fiebeler; F Schmidt; Dominik N Müller; Joon-Keun Park; Ralf Dechend; M Bieringer; Erdenechimeg Shagdarsuren; V Breu; Hermann Haller; Friedrich C Luft
Mineralocorticoid receptor affects AP-1 and nuclear factor-kappab activation in angiotensin II-induced cardiac injury.
Hypertension 2001;37(2 Pt 2):787-93.